Clinical Trial

Bimzelx (Bimekizumab) For The Treatment Of Adult Onset PRP

Name: Bimzelx (Bimekizumab) For The Treatment Of Adult Onset PRP — clinical trial record (NCT07497620)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The purpose of this study is to valuate the clinical efficacy of Bimzelx therapy in adults with Pityriasis Rubra Pilaris.

Trial Details

NCT Number	NCT07497620
Lead Sponsor	Mayo Clinic
Conditions	Pityriasis Rubra Pilaris
Enrollment	12 participants
Start Date	2026-07-01
Primary Completion	2027-08-01 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-27